Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter seriesAlessandra Iurlo, Michele Baccarani, Sara Galimberti et al.|Annals of Hematology|2017Cited by 38
Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 × 10 <sup>9</sup> /L to <100 × 10 <sup>9</sup> /L) at baseline: the final analysis of EXPANDPaola Guglielmelli, Heinz Gisslinger, Haitao Meng et al.|Therapeutic Advances in Hematology|2022Cited by 11